Article
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.
Cancer letters - 1 Jun 2016
Braekeveldt Noémie, Wigerup Caroline, Tadeo Irene, Beckman Siv, Sandén Caroline, Jönsson Jimmie, Erjefält Jonas S, Berbegall Ana P, Börjesson Anna, Backman Torbjörn, Øra Ingrid, Navarro Samuel, Noguera Rosa, Gisselsson David, Påhlman Sven, Bexell Daniel
Abstract excerpt
Treatment of high-risk childhood neuroblastoma is a clinical challenge which has been hampered by a lack of reliable neuroblastoma mouse models for preclinical drug testing. We have previously established invasive and metastasising patient-derived orthotopic xenografts (PDXs) from high-risk neuroblastomas that retained the genotypes and phenotypes of patient tumours. Given the important role of the tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
